Israel Biotech Fund
John Oppenheimer is a Venture Advisor at Israel Biotech Fund. John is also the Director of Clinical Research at Pulmonary, Allergy Associates & Clinical Professor of Medicine at the New Jersey Medical School. Dr. Oppenheimer is board-certified in Internal Medicine and Allergy and Immunology.
Dr. Oppenheimer has participated in well over 100 clinical studies with over 160 publications and has received numerous awards regarding his contributions in the field of allergy.
He serves as both the associate and section editor of the Annals of Allergy Asthma and Immunology, co-section editor of Current Reports of Allergy and Immunology and serves as a reviewer for the Journal of Allergy and Clinical Immunology.
He is past chairman of the American Board of Allergy and Immunology, was a member of the PCPI, and is an ambassador for the American Board of Medical Specialists.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Israel Biotech Fund
Israel Biotech Fund seeks high-value returns by identifying and maximizing the success of therapeutic assets of Israel-based biotech companies. Their key asset is a unique team of 25 Venture Advisors, comprised of renowned industry leaders and professionals who, together with the fund’s managing partners, provide their portfolio companies with hands-on guidance and support.